US Markets
Home›US Markets›Sectors›China poses a risk to biotech’s recent rally
China poses a risk to biotech’s recent rally
The Wall Street Journal Markets highlights China as a potential headwind to the biotech sector’s strong performance, framing it as a threat to the group’s ongoing bull run.
The outlet also points to other investing themes within the market, including a defense-stock opportunity, and separately notes timber as another sector-specific story.
← Newer storyKalshi partners with The Weather Company to improve weather contract…Older story →UK shoppers boost legume purchases as prices push diet shifts